Basics |
Cogent Biosciences, Inc.
|
IPO Date: |
March 26, 2018 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$1.82B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.27 | 3.20%
|
Avg Daily Range (30 D): |
$0.21 | 1.80%
|
Avg Daily Range (90 D): |
$0.22 | 2.78%
|
Institutional Daily Volume |
Avg Daily Volume: |
.59M |
Avg Daily Volume (30 D): |
1.14M |
Avg Daily Volume (90 D): |
1.98M |
Trade Size |
Avg Trade Size (Sh.): |
108 |
Avg Trade Size (Sh.) (30 D): |
75 |
Avg Trade Size (Sh.) (90 D): |
109 |
Institutional Trades |
Total Inst.Trades: |
1,701 |
Avg Inst. Trade: |
$1.61M |
Avg Inst. Trade (30 D): |
$1.86M |
Avg Inst. Trade (90 D): |
$1.68M |
Avg Inst. Trade Volume: |
.18M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.8M |
Avg Closing Trade (30 D): |
$2.45M |
Avg Closing Trade (90 D): |
$2.41M |
Avg Closing Volume: |
190.84K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-1.78
|
$-.53
|
$-.52
|
Diluted EPS
|
$-1.78
|
$-.53
|
$-.52
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -284.08M
|
$ -73.53M
|
$ -71.99M
|
Operating Income / Loss
|
$ -299.66M
|
$ -75.58M
|
$ -74.93M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 39.38M
|
$ 1.6M
|
$ 27.84M
|
PE Ratio
|
|
|
|
|
|
|